Search

Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2009 Page: 47-50
Author(s): D. Digiuseppe, C. Feliciani

Anti-Tumor Necrosis Factor-α Therapy in Undifferentiated Spondyloarthritis (USpA)

Journal: Current Rheumatology Reviews
Volume: 5 Issue: 3 Year: 2009 Page: 174-176
Author(s): Hsien-Tzung Liao, Chun-Hsiung Chen, Wei-Sheng Chen, Hui-Ting Lee, Chang-Youh Tsai, Chung-Tei Chou

Tumor Necrosis Factor Inhibitors in Pediatric Asthma

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 3 Issue: 2 Year: 2009 Page: 143-148
Author(s): Daniela Gjurow, Tomasz Grzelewski, Agnieszka Sobocinska, Iwona Stelmach

Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family

Journal: Current Drug Targets
Volume: 10 Issue: 2 Year: 2009 Page: 94-103
Author(s): E. Bremer, M. de Bruyn, H. Wajant, W. Helfrich

Targeting the Tumor Stroma in Cancer Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 10 Issue: 2 Year: 2009 Page: 185-191
Author(s): Kevin Anton, John Glod

Journal: Current Radiopharmaceuticals
Volume: 2 Issue: 3 Year: 2009 Page: 191-194
Author(s): A. Gasbarrini, M. Cappuccio, H. Li, R. Donthineni, L. Boriani, S. Bandiera, L. Foroni, G. Pasquinelli, S. Boriani

Lymphangiogenesis and Anti-Tumor Immune Responses

Journal: Current Molecular Medicine
Volume: 9 Issue: 6 Year: 2009 Page: 694-701
Author(s): Michelle L. Varney, Seema Singh, Matthew Backora, Zhengtang Chen, Rakesh K. Singh

III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1854-1867
Author(s): Mitsuko Furuya, Yoshikazu Yonemitsu, Ichiro Aoki

Saponins as Tool for Improved Targeted Tumor Therapies

Journal: Current Drug Targets
Volume: 10 Issue: 2 Year: 2009 Page: 140-151
Author(s): H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland, C. Bachran

Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 6 Year: 2009 Page: 777-788
Author(s): J. C. Doloff, N. Khan, J. Ma, E. Demidenko, H. M. Swartz, Y. Jounaidi